title: [Remote monitoring of implantable cardiac devices: health technology assessment ].
abstract: Clinical follow-up of patients with cardiac implantable electronic devices is challenging because of the increasing technical complexity of devices and clinical complexity of patients. Remote monitoring (RM) offers the opportunity to optimize clinic workflow and to improve device monitoring and patient management by reducing in-hospital visits, physician and nurse time required for patient follow-up, and hospital and social costs. Continuous RM may lead to early detection of device malfunctions and clinical events, such as arrhythmias and heart failure. Early reaction may improve patient outcome. RM is easy to use and patients show a high level of acceptance and satisfaction. Implementing RM in daily practice may require changes in clinical workflow. Primary nursing-based models have demonstrated the best results. In spite of a favorable cost-benefit ratio, RM reimbursement still represents an issue in several European countries, including Italy, which limits widespread RM utilization. The fee-for-service payment approach, the global budget for device patient follow-up and/or integrated care packages for heart failure management represent the keys to introduce reimbursement and to improve patient care, while reducing healthcare costs.
authors.forename: Renato Pietro
authors.initials: RP
authors.lastname: Ricci
authors.forename: Emanuela Teresa
authors.initials: ET
authors.lastname: Locati
authors.forename: Andrea
authors.initials: A
authors.lastname: Campana
authors.forename: Ciro
authors.initials: C
authors.lastname: Cavallaro
authors.forename: Massimo
authors.initials: M
authors.lastname: Giammaria
authors.forename: Maurizio
authors.initials: M
authors.lastname: Landolina
authors.forename: Maurizio
authors.initials: M
authors.lastname: Marzegalli
authors.forename: Donato
authors.initials: D
authors.lastname: Melissano
mesh_terms: D001145:Arrhythmias, Cardiac / Q000191:economics* / Q000628:therapy*; D003362:Cost-Benefit Analysis; D017147:Defibrillators, Implantable / Q000191:economics*; D005062:European Union; D006801:Humans; D007558:Italy; D008991:Monitoring, Physiologic / Q000191:economics; D010138:Pacemaker, Artificial / Q000191:economics*; D017060:Patient Satisfaction; D013673:Technology Assessment, Biomedical; D017216:Telemedicine / Q000191:economics*